Anti-CD22 Calecheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azatabine in the Treatment of Mixed Phenotype Acute Leukemia: A Case Report.

Li, Kongfei; Wang, Yuxiao; Pei, Renzhi; Lu, Ying; Cao, Junjie; Zhuang, Xianxu; Lian, Jiaying; Zhang, Bibo

Li, Kongfei; Wang, Yuxiao; Pei, Renzhi; Lu, Ying; Cao, Junjie; Zhuang, Xianxu; Lian, Jiaying; Zhang, Bibo.

Afiliação

Li K; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Zhejiang, China.
Wang Y; Ningbo University, Institute of Hematology, Department of Hematology, Zhejiang, China.
Pei R; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Zhejiang, China.
Lu Y; Ningbo University, Institute of Hematology, Department of Hematology, Zhejiang, China.
Cao J; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Zhejiang, China.
Zhuang X; Ningbo University, Institute of Hematology, Department of Hematology, Zhejiang, China.
Lian J; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Zhejiang, China.
Zhang B; Ningbo University, Institute of Hematology, Department of Hematology, Zhejiang, China.

Turk J Haematol ; 2024 Jul 30.

Article em En | MEDLINE | ID: mdl-39078014

Palavras-chave

inotuzumab ozogamicin; mixed-phenotype acute leukemia; targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Turk J Haematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google